Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,117 shares at $2.58 ($2,882)
  2. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 853 shares at $2.61 ($2,226)
  3. 4 Open-market buy Director bought 4,115 shares at $2.46 ($10,123)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 44,963 shares (grant or award)
  12. 4 Grant or award CHIEF MEDICAL OFFICER acquired 44,963 shares (grant or award)
  13. 4 Grant or award EVP & CHIEF FINANCIAL OFFICER acquired 44,963 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award EVP & CHIEF INNOVATION OFFICER acquired 44,963 shares (grant or award)
  16. 4 Grant or award EVP & CHIEF BUSINESS OFFICER acquired 44,963 shares (grant or award)
  17. 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,521 shares at $2.96 ($16,342)
  18. 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,515 shares at $2.97 ($16,380)
  19. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 8,345 shares at $2.91 ($24,284)
  20. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 6,618 shares at $2.95 ($19,523)

Page 3 of 11 · 206 filings